+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain Drug"

Neuropathic Pain Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neuropathic Pain Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
Neuropathic Pain Drug Market in the United States - Product Thumbnail Image

Neuropathic Pain Drug Market in the United States

  • Report
  • March 2026
  • 210 Pages
  • United States
From
Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • September 2026
  • 386 Pages
  • Global
From
Neuropathic Pain Market Report 2026 - Product Thumbnail Image

Neuropathic Pain Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetic Neuropathic Pain - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
From
Chronic Neuropathic Pain Pipeline Analysis Report 2025 - Product Thumbnail Image

Chronic Neuropathic Pain Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
From
Neuropathy Pain Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neuropathy Pain Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Pregabalin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pregabalin Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
Neuralgia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neuralgia Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 197 Pages
  • Global
From
Anticonvulsants Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anticonvulsants Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Peripheral Neuropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Peripheral Neuropathy Treatment - Global Strategic Business Report

  • Report
  • September 2026
  • 273 Pages
  • Global
From
Pregabalin Market - Global Strategic Business Report - Product Thumbnail Image

Pregabalin Market - Global Strategic Business Report

  • Report
  • September 2026
  • 372 Pages
  • Global
From
Paresthesia Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment Market - Global Strategic Business Report

  • Report
  • September 2026
  • 381 Pages
  • Global
From
Diabetic Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Diabetic Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • September 2026
  • 384 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • September 2026
  • 276 Pages
  • Global
From
Loading Indicator

The Neuropathic Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathic pain drugs are used to treat chronic pain caused by nerve damage, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. These drugs are typically divided into two categories: anticonvulsants and antidepressants. Anticonvulsants are used to reduce the intensity of nerve pain, while antidepressants are used to reduce the frequency of nerve pain. Commonly prescribed neuropathic pain drugs include pregabalin, gabapentin, duloxetine, and amitriptyline. Some companies in the Neuropathic Pain Drug market include Pfizer, GlaxoSmithKline, Eli Lilly, and Novartis. Show Less Read more